EXACT SCIENCES CORP

Provides advanced cancer screening and diagnostic tests for early detection and treatment guidance.

EXAS | NDAQ

Overview

Corporate Details

ISIN(s):: US30063P1057
LEI:
Country:: United States of America
Address:: 5505 ENDEAVOR LANE, 53719 MADISON
Website:: https://www.exactsciences.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Exact Sciences Corp. is a molecular diagnostics company focused on eradicating cancer through prevention, early detection, and personalized therapy guidance. The company develops and markets a portfolio of advanced cancer screening and diagnostic tests. These products and services are designed to assess hereditary risks, screen for the presence of cancer, and analyze the unique genomic profile of tumors to help guide treatment decisions for patients and healthcare providers. Leveraging rigorous scientific research and state-of-the-art laboratory services, Exact Sciences aims to provide actionable insights across the entire cancer care continuum, from initial risk assessment to post-treatment monitoring, with a key focus on early-stage disease detection.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all EXACT SCIENCES CORP filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for EXACT SCIENCES CORP

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for EXACT SCIENCES CORP via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Atara Biotherapeutics, Inc. Pioneering off-the-shelf allogeneic T-cell immunotherapies for cancer and autoimmune diseases.	United States of America	ATRA
Atea Pharmaceuticals, Inc. A clinical-stage biopharma developing oral antiviral therapies for viruses like Hepatitis C.	United States of America	AVIR
Athira Pharma, Inc. Developing small-molecule therapies to slow neurodegeneration in diseases like Alzheimer's.	United States of America	ATHA
ATOSSA THERAPEUTICS, INC. Clinical-stage biopharma developing (Z)-endoxifen for breast cancer treatment and prevention.	United States of America	ATOS
ATUM CO., LTD. Bioengineering solutions to accelerate life sciences research, from gene synthesis to cell lines.	South Korea	355690
aTYR PHARMA INC Developing novel medicines for fibrosis and inflammation using tRNA synthetase biology.	United States of America	ATYR
Aura Biosciences, Inc. Developing virus-like therapies to selectively destroy solid tumors in ocular & urologic oncology.	United States of America	AURA
Aurinia Pharmaceuticals Inc. Biopharma developing therapies for autoimmune and kidney diseases like lupus nephritis.	United States of America	AUPH
AURORA CANNABIS INC A global producer and seller of medical and recreational cannabis and derivative products.	United States of America	ACB
Autolus Therapeutics plc Develops programmed CAR T-cell therapies for cancer and autoimmune diseases.	United States of America	AUTL